Indian state unable to obtain Covid-19 shots directly from Moderna

  • Indian state unable to obtain Covid-19 shots directly from Moderna

Indian state unable to obtain Covid-19 shots directly from Moderna

Moderna Inc says its coronavirus vaccine appears to be safe and effective in children ages 12 to 17.

Kejriwal told the local media that the vaccine makers have said that "they will deal with the central government". Vax is the key, but govt doesn't care: Rahul GandhiAmid shortage of vaccines, Congress leader Rahul Gandhi on Monday attacked the government saying it is not "serious" about it. Rahul Gandhi tweeted on Monday, "Vaccination is the key to controlling the pandemic but GOI doesn't seem to care".

Agarwal was responding to questions on what the Centre is doing as as foreign manufacturers including Moderna and Pfizer have refused to sell to the States.

Kejriwal added: "We need vaccines".

"We're coordinating with (Pfizer and Moderna) on central level in 2 ways - approval and procurement". Why is it not being done urgently?

India now has three vaccines - Covishield (developed by AstraZeneca-Oxford University), Covaxin (developed by Bharat Biotech) and Sputnik V. "However, Bharat Biotech has struck a deal with only two companies".

India has an estimated 950 million people 18 years or older for whom the country would require at least 1.9 billion doses, or a production capacity of 158 million doses per month for full immunisation within a year. There are less than 18,000 cases in the USA.

According to the unit, Janssen Pharmaceutical K.K., its Phase 1 study results from 250 healthy people between the ages of 20 and 55 and those aged 65 or older in Japan showed that the one-shot vaccine did not pose safety risks. "Covaxin [stock in Delhi] is over but Covishield is left for a few days".

Similarly, Delhi Chief Minister Arvind Kejriwal said that Pfizer and Moderna had conveyed to his government that they will not be able to directly sell vaccines but would only deal with the Centre.

The centre - heavily criticised over vaccinations - said it would supply 50 per cent of doses. "The Central government has made vaccines a joke in India", Sisodia said. It has failed to manage the situation. In a press release, the company also said the vaccine appeared 93% effective two weeks after the first dose.

Deputy Chief Minister Manish Sisodia also lashed out at the Centre for its "poor planning".

Like other COVID-19 vaccine players, Moderna has been busy with its production efforts.

Since the COVID-19 vaccine rollouts started late previous year, the shots have brought in billions for the leading companies. We were sleeping back then and are still sleeping. "Apart from India, Moderna has been distributed in 46 nations and Johnson & Johnson in 41 countries. The vaccines which the Centre has asked us to buy from outside have not even been approved in the country yet", he said. "It is a matter of great concern as those given the first dose of Covaxin a month ago are due to get their second jab soon". The US had started procuring vaccines right from their trial stages and today, it has enough doses for each of its citizens.

"The Centre did not even order vaccines from Serum or Bharat (Biotech) until January this year - and that too in bits and pieces", Ramakumar said. "The Indian government pumped in money to increase production only last month whereas the United States started investing in production of vaccines in March, 2020", Sisodia said.